AIM
SPHS

Alambic Investment Management’s Sophiris Bio, Inc. SPHS Stock Holding History

Alambic Investment Management’s Portfolio SPHS Stock Details SPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-24,200
Closed -$35K – 636
2016
Q1 		$35K Sell
24,200
-12,500
-34% -$22K 0.01% 476
2015
Q4 		$65K Buy
+36,700
New +$54.3K 0.04% 349

Other funds holding SPHS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Alambic Investment Management's SPHS Position: Q2 2016 in Review

Alambic Investment Management sold out of Sophiris Bio, Inc. (SPHS) in Q2 2016, closing a stake of 24,200 shares — an estimated $35K sold.

Alambic Investment Management first reported a position in SPHS in Q4 2015 and held it in 2 quarters. The position peaked at $65K in Q4 2015. 19 funds tracked by Wall St. Rank hold SPHS as of Q2 2016.

  • Alambic Investment Management reported no remaining Sophiris Bio, Inc. position as of Q2 2016 after selling out during the quarter.
  • Alambic Investment Management sold 24,200 Sophiris Bio, Inc. shares in Q2 2016, an estimated $35K.
  • Alambic Investment Management first reported a position in Sophiris Bio, Inc. in Q4 2015 and held it in 2 quarters.
  • Alambic Investment Management's Sophiris Bio, Inc. position peaked at $65K in Q4 2015.
  • 19 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q2 2016.

Based on Alambic Investment Management's 13F filing for Q2 2016, filed 8 Aug 2016.